NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
Clinical trial NCT07683325 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07683325
- Sponsor
- Agomab Spain S.L.U.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-30
- Primary completion
- 2028-12-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.